Nutex Health Inc.
NUTX
$90.28
-$15.06-14.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -43.36% | 9.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -43.36% | 9.76% | |||
| Cost of Revenue | -13.03% | -5.18% | |||
| Gross Profit | -63.83% | 22.83% | |||
| SG&A Expenses | -488.68% | -73.13% | |||
| Depreciation & Amortization | 3.68% | -4.67% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -97.26% | -34.65% | |||
| Operating Income | 13.46% | 287.09% | |||
| Income Before Tax | -79.11% | 422.24% | |||
| Income Tax Expenses | -65.78% | 257.67% | |||
| Earnings from Continuing Operations | -82.84% | 499.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 88.46% | -22.23% | |||
| Net Income | -78.65% | 413.25% | |||
| EBIT | 13.46% | 287.09% | |||
| EBITDA | 13.10% | 247.75% | |||
| EPS Basic | -79.77% | 380.23% | |||
| Normalized Basic EPS | 121.94% | 269.88% | |||
| EPS Diluted | -79.84% | 362.87% | |||
| Normalized Diluted EPS | 137.71% | 258.61% | |||
| Average Basic Shares Outstanding | 5.52% | 11.78% | |||
| Average Diluted Shares Outstanding | -1.48% | 19.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||